Key Takeaways:
· Global regulations like the EU Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act are pushing companies to modernize supply chains with trackable product identification and real-time data systems.
· Loftware’s research underscores how volatility has become the defining feature of today’s supply chains, yet many organizations are not prepared.
· Authenticity and traceability are now essential in modern supply chains, accelerated by initiatives like Digital Product Passports and next-generation 2D barcodes.
Life sciences companies face stringent requirements around traceability, serialization, and anti-counterfeiting, particularly for pharmaceuticals and medical devices. Because of these requirements and regulations, the race is on for companies of all size to modernize their supply chains.
“Global regulations like the EU Falsified Medicines Directive (FMD) and the U.S. Drug Supply Chain Security Act (DSCSA) are pushing companies to modernize supply chains with connected, trackable product identification and real-time data systems,” says Laura Johnson, senior director of life sciences, Loftware, a global leader in product identification and supply chain transparency.
Earlier this month the company released its 2026 Top 5 Trends Report, revealing that businesses worldwide are moving urgently to modernize their supply chains in the face of unprecedented disruption, geopolitical uncertainty, and increasing regulatory demands.
The report draws on insights from more than 400 supply chain professionals across 55 countries, and highlights a decisive shift toward connected supplier networks, real-time packaging intelligence, and AI-enabled automation as organizations work to strengthen resilience and stay competitive in an unpredictable global landscape.
“The future of supply chains will be defined by agility and intelligence,” says Jim Bureau, President & CEO of Loftware. “Our research shows that organizations adopting connected networks, cloud platforms, and AI-driven insights are not just surviving disruption but turning it into opportunity. By modernizing today, companies can anticipate challenges, act in real time, and create supply chains that are smarter, faster, and ready for whatever comes next.”
Looming Disruptions
Loftware’s research underscores how volatility has become the defining feature of today’s supply chains. Yet many organizations remain unprepared: according to Gartner data, only 29% of companies are ready to manage the next wave of supply chain challenges, whatever they may be.
“Disruptions could come from geopolitical tensions, trade restrictions, or global health crises like we saw with COVID-19,” says Johnson. “Natural disasters, cyberattacks on digital supply chains, and sudden changes in regulatory requirements can also interrupt production and distribution of critical life sciences products.”
At the same time, financial pressure is intensifying. Among companies surveyed with a revenue of $1 billion or more, 50% expect tariffs or trade restrictions to cost them over $1 million in the coming year, with nearly one in five anticipating an impact exceeding $10 million.
“Tariffs are increasing costs and forcing companies to rethink sourcing and logistics,” says Johnson. “Broader industry data from McKinsey shows over 80% of companies report supply chain effects from tariffs, with supplier and material costs rising just under 40%. In life sciences, where timing, compliance, and patient access are critical, these pressures are driving strategic shifts such as supplier diversification, nearshoring, and network reconfiguration.”
According to Loftware’s report, companies are responding by accelerating investment in solutions that unify supplier ecosystems, ensure consistent and compliant product data, and reduce the operational friction caused by siloed processes. Nearly 70% of respondents believe that sharing label data and standards with trading partners would help them respond faster to disruptions; an indication that the industry is moving quickly toward more collaborative and connected networks.
“Connected networks enable real-time visibility across all trading partners, improving coordination and responsiveness. Collaboration allows for proactive issue resolution, better inventory management, and more agile distribution, reducing delays and ensuring critical medications and devices reach patients safely,” says Johnson.
Organizations that have already adopted such models report measurable gains, including 48% citing faster problem resolution and 37% citing reduced operational costs.
Getting The Most Out of Your Data
The findings also reveal that geopolitical uncertainty is forcing businesses to rethink compliance strategies. Many organizations still struggle to adapt product data and labeling processes to new tariffs or regulatory changes, with 63% of $1B+ companies calling these adjustments “very” or “somewhat difficult.” As supply chains move through reshoring, nearshoring, and multi-sourcing, cloud-based labeling is essential for accuracy and compliance across shifting supplier networks, helping companies avoid costly delays, border holds, and penalties.
Consumer expectations are driving transformation as well. Smart packaging, powered by real-time label data, dynamic QR codes, and connected product information, is emerging as a critical tool for improving engagement, sustainability, and operational efficiency. According to the research, 91% of respondents believe real-time label data helps reduce waste, errors, and improves efficiency. But how many companies are actually utlizing this technology?
“While most life sciences companies recognize the value of real-time label data, actual adoption across operations varies. Many are using it in parts of their product identification processes, but full integration across global supply chains and regulatory systems remains challenging,” reports Johnson.
“However, when paired with connected packaging, real-time label data delivers even greater visibility and impact. Digital identifiers, like serialized codes and QR codes, extend the reach of label data, linking it to the product throughout its lifecycle. This approach not only increases adoption of real-time data but also improves compliance, reduces labeling errors, enables faster recalls, and minimizes waste.”
While not all companies are utilizing connected packaging today, most see the benefits of it. In fact, according to the report, most view enhanced traceability (64%) and improved consumer engagement (44%) as the top benefits of connected packaging.
“Most life sciences supply chains are only partially connected. While serialization and track-and-trace systems exist, data silos, legacy systems, and inconsistent global standards still limit real-time visibility and agility,” says Johnson.
But, things are improving. Authenticity and traceability are now essential in modern supply chains, accelerated by initiatives like Digital Product Passports and next-generation 2D barcodes. With consumers, regulators, and trading partners demanding verifiable product information, 88% of respondents say cloud-based product identification platforms establish a single source of truth to ensure accurate tracking, traceability, and authenticity.
Loftware’s report shows that autonomous supply chain technologies are gaining traction. Powered by SaaS-based labeling platforms, AI analytics, and integrated data, these systems help detect disruptions earlier, optimize logistics in real time, and automate error-prone processes. Seventy-five percent of respondents use SaaS-based labeling for resilience, citing benefits like higher efficiency (41%), fewer errors (37%), lower waste (33%), and faster response (30%). As companies face greater complexity across supplier networks, these capabilities will play a central role in building supply chains that are not just connected, but intelligent and self-optimizing.
